Reliability and Validity of the French Version of the Virtual Reality Sickness Questionnaire
NCT ID: NCT06466590
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2024-07-01
2025-05-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motion Sickness Desensitization Using VR
NCT05628220
Virtual Reality and Relaxation for the Treatment of Generalized Anxiety Disorders: a Comparative Study With Standard Relaxation
NCT02571790
Turkish Adaptation of the CSQ-VR
NCT07247773
Virtual Reality Sickness Questionnaire: Psychometrics in Stroke Patients
NCT07297862
The Effective of Immersive Virtual Reality Distraction on Memory: Study 1
NCT07172230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Group
Participants will be asked to use the measurement instrument VRSQ-F on two separate occasions under identical conditions to assess its test-retest reliability and asked to use the SSQ for validity. Each session will involve completing the measurement protocol as specified.
Use of Measurement Instrument
Participants will complete the measurement procedure twice, with sessions scheduled one week apart, using the same instrument under standardized conditions. The results from both sessions will be compared to assess the instrument's consistency and accuracy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of Measurement Instrument
Participants will complete the measurement procedure twice, with sessions scheduled one week apart, using the same instrument under standardized conditions. The results from both sessions will be compared to assess the instrument's consistency and accuracy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men or women aged 18 to 65
* Person affiliated to a social security scheme
* Healthy person with no particular medical condition
* Having given their consent to participate in the research
For patients :
* Men or women aged 18 to 65
* Persons affiliated to a social security scheme
* People undergoing regular rehabilitation, walking or in a wheelchair, who can use a virtual reality solution as part of their care.
* Having given their consent to take part in the research
Exclusion Criteria
* Cognitive and language disorders
* Persons under legal protection
* Pregnant women
* MSSQ greater than 15
* People suffering from photosensitive epilepsy
* Persons under the influence of medication that may impair drugs or alcohol
* Participant with an implanted medical device that may be affected by radio waves emitted by compatible third-party equipment (e.g. : Pacemaker)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pôle Saint Hélier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emilie LEBLONG
Role: PRINCIPAL_INVESTIGATOR
Pôle Saint Hélier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de Rééducation Fonctionnelle Neurologique PROPARA
Montpellier, , France
Pôle Saint-Hélier
Rennes, , France
Fondation Ildys
Roscoff, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02468-37
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.